Search Results - Yanagitani, Noriko

Refine Results
  1. 1
    Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer

    Prospective exploratory study of gemcitabine and S-1 against elderly patients with advanced non-small cell lung cancer by Kaira, Kyoichi, Yanagitani, Noriko, Sunaga, Noriaki, Imai, Hisao, Ono, Akihiro, Koga, Yasuhiko, Hisada, Takeshi, Ishizuka, Tamotsu, Yamada, Masanobu

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Multiple lung metastases presenting as ground-glass opacities in a pulmonary adenocarcinoma: a case report

    Multiple lung metastases presenting as ground-glass opacities in a pulmonary adenocarcinoma: a case report by Yanagitani, Noriko, Kaira, Kyoichi, Ishizuka, Tamotsu, Aoki, Haruka, Utsugi, Mitsuyoshi, Shimizu, Yasuo, Sunaga, Noriaki, Endou, Katsuaki, Hisada, Takeshi, Mori, Masatomo

    Published 2009
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Elemental analysis of lung tissue particles and intracellular iron content of alveolar macrophages in pulmonary alveolar proteinosis

    Elemental analysis of lung tissue particles and intracellular iron content of alveolar macrophages in pulmonary alveolar proteinosis by Shimizu, Yasuo, Matsuzaki, Shinichi, Dobashi, Kunio, Yanagitani, Noriko, Satoh, Takahiro, Koka, Masashi, Yokoyama, Akihito, Ohkubo, Takeru, Ishii, Yasuyuki, Kamiya, Tomihiro, Mori, Masatomo

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    A phase II study of S-1 in relapsed small cell lung cancer

    A phase II study of S-1 in relapsed small cell lung cancer by KUDO, KEITA, OHYANAGI, FUMIYOSI, HORIIKE, ATSUSHI, MIYAUCHI, EISAKU, TAHANAKA, HISASHI, YANAGITANI, NORIKO, SAITO, RYOUTA, KABURAKI, KYOUHEI, SAKATANI, TOSHIO, HORAI, TAKESHI, NISHIO, MAKOTO

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab

    Lung Adenocarcinoma with Lynch Syndrome and the Response to Nivolumab by Kawashima, Yosuke, Nishikawa, Shingo, Ninomiya, Hironori, Yoshida, Reiko, Takano, Natsuki, Oguri, Tomoyo, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Ishikawa, Yuichi, Nishio, Makoto

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer

    GSK3 inhibition circumvents and overcomes acquired lorlatinib resistance in ALK-rearranged non-small-cell lung cancer by Shimizu, Yuki, Okada, Koutaroh, Adachi, Jun, Abe, Yuichi, Narumi, Ryohei, Uchibori, Ken, Yanagitani, Noriko, Koike, Sumie, Takagi, Satoshi, Nishio, Makoto, Fujita, Naoya, Katayama, Ryohei

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer

    Overcoming resistance by ALK compound mutation (I1171S + G1269A) after sequential treatment of multiple ALK inhibitors in non‐small cell lung cancer by Takahashi, Ken, Seto, Yosuke, Okada, Koutaroh, Uematsu, Shinya, Uchibori, Ken, Tsukahara, Mika, Oh‐hara, Tomoko, Fujita, Naoya, Yanagitani, Noriko, Nishio, Makoto, Okubo, Kenichi, Katayama, Ryohei

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (TOPGAN2020‐02)

    Clinical efficacy of dacomitinib in rechallenge setting for patients with epidermal growth factor receptor mutant non–small cell lung cancer: A multicenter retrospective analysis (... by Tanaka, Hisashi, Sakamoto, Hiroaki, Akita, Takahiro, Ohyanagi, Fumiyoshi, Kawashima, Yosuke, Tambo, Yuichi, Tanimoto, Azusa, Horiike, Atsushi, Miyauchi, Eisaku, Tsuchiya‐Kawano, Yuko, Yanagitani, Noriko, Nishio, Makoto

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer

    Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in surgically resectable stage III non-small cell lung cancer by KAIRA, KYOICHI, ORIUCHI, NOBORU, IMAI, HISAO, SHIMIZU, KIMIHIRO, YANAGITANI, NORIKO, SUNAGA, NORIAKI, HISADA, TAKESHI, KAWASHIMA, OSAMU, KAMIDE, YOSUKE, ISHIZUKA, TAMOTSU, KANAI, YOSHIKATSU, NAKAJIMA, TAKASHI, MORI, MASATOMO

    Published 2010
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer

    EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer by Sonoda, Tomoaki, Nishikawa, Shingo, Sakakibara, Rie, Saiki, Masafumi, Ariyasu, Ryo, Koyama, Junji, Kitazono, Satoru, Yanagitani, Noriko, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms

    Drug resistance mechanisms in Japanese anaplastic lymphoma kinase‐positive non–small cell lung cancer and the clinical responses based on the resistant mechanisms by Yanagitani, Noriko, Uchibori, Ken, Koike, Sumie, Tsukahara, Mika, Kitazono, Satoru, Yoshizawa, Takahiro, Horiike, Atsushi, Ohyanagi, Fumiyoshi, Tambo, Yuichi, Nishikawa, Shingo, Fujita, Naoya, Katayama, Ryohei, Nishio, Makoto

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2

    Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2 by Uchibori, Ken, Takano, Natsuki, Manabe, Ryo, Tsugitomi, Ryosuke, Ogusu, Shinsuke, Tozuka, Takehiro, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Ariyasu, Ryo, Kitazono, Satoru, Yanagitani, Noriko, Nishio, Makoto

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib

    Characteristics of central nervous system progression in non‐small cell lung cancer treated with crizotinib or alectinib by Sakamoto, Hiroaki, Yanagitani, Noriko, Manabe, Ryo, Tsugitomi, Ryosuke, Ogusu, Shinsuke, Tozuka, Takehiro, Yoshida, Hiroshi, Amino, Yoshiaki, Ariyasu, Ryo, Uchibori, Ken, Kitazono, Satoru, Tasaka, Sadatomo, Nishio, Makoto

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor

    Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor by Sakai, Kazuko, Horiike, Atsushi, Irwin, Darryl L., Kudo, Keita, Fujita, Yoshihiko, Tanimoto, Azusa, Sakatani, Toshio, Saito, Ryota, Kaburaki, Kyohei, Yanagitani, Noriko, Ohyanagi, Fumiyoshi, Nishio, Makoto, Nishio, Kazuto

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer

    Secreted PD-L1 variants mediate resistance to PD-L1 blockade therapy in non–small cell lung cancer by Gong, Bo, Kiyotani, Kazuma, Sakata, Seiji, Nagano, Seiji, Kumehara, Shun, Baba, Satoko, Besse, Benjamin, Yanagitani, Noriko, Friboulet, Luc, Nishio, Makoto, Takeuchi, Kengo, Kawamoto, Hiroshi, Fujita, Naoya, Katayama, Ryohei

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell lung cancer

    Correlation between thyroid transcription factor-1 expression, immune-related thyroid dysfunction, and efficacy of anti-programmed cell death protein-1 treatment in non-small cell... by Koyama, Junji, Horiike, Atsushi, Yoshizawa, Takahiro, Dotsu, Yosuke, Ariyasu, Ryo, Saiki, Masafumi, Sonoda, Tomoaki, Uchibori, Ken, Nishikawa, Shingo, Kitazono, Satoru, Yanagitani, Noriko, Ninomiya, Hironori, Ishikawa, Yuichi, Nishio, Makoto

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients

    Barcode sequencing identifies resistant mechanisms to epidermal growth factor receptor inhibitors in circulating tumor DNA of lung cancer patients by Kitazono, Satoru, Sakai, Kazuko, Yanagitani, Noriko, Ariyasu, Ryo, Yoshizawa, Takahiro, Dotsu, Yosuke, Koyama, Junji, Saiki, Masafumi, Sonoda, Tomoaki, Nishikawa, Shingo, Uchibori, Ken, Horiike, Atsushi, Nishio, Kazuto, Nishio, Makoto

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer

    Association Between the Efficacy of Pembrolizumab and Low STK11/LKB1 Expression in High-PD-L1-expressing Non-small-cell Lung Cancer by HASEGAWA, TSUKASA, YANAGITANI, NORIKO, NINOMIYA, HIRONORI, SAKAMOTO, HIROAKI, TOZUKA, TAKEHIRO, YOSHIDA, HIROSHI, AMINO, YOSHIAKI, UEMATSU, SHINYA, YOSHIZAWA, TAKAHIRO, ARIYASU, RYO, UCHIBORI, KEN, KITAZONO, SATORU, HORIIKE, ATSUSHI, NISHIO, MAKOTO

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice

    Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice by Ariyasu, Ryo, Uchibori, Ken, Ninomiya, Hironori, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Manabe, Ryo, Sakamaoto, Hiroaki, Tozuka, Takehiro, Yoshida, Hiroshi, Amino, Yoshiaki, Kitazono, Satoru, Yanagitani, Noriko, Takeuchi, Kengo, Nishio, Makoto

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand 1 inhibitors

    Dissociated responses at initial computed tomography evaluation is a good prognostic factor in non-small cell lung cancer patients treated with anti-programmed cell death-1/ligand... by Tozuka, Takehiro, Kitazono, Satoru, Sakamoto, Hiroaki, Yoshida, Hiroshi, Amino, Yoshiaki, Uematsu, Shinya, Yoshizawa, Takahiro, Hasegawa, Tsukasa, Uchibori, Ken, Yanagitani, Noriko, Horiike, Atsushi, Horai, Takeshi, Seike, Masahiro, Gemma, Akihiko, Nishio, Makoto

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: